Patents by Inventor Natarajan Tamilarasu

Natarajan Tamilarasu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
    Patent number: 7056656
    Abstract: This invention relates to the use of oligourea molecules to specifically inhibit protein-nucleic acid interactions. In particular, it provides an oligourea molecule that competes with the Tat molecule for the TAR RNA of HIV-1. Also provided is a method specifically inhibiting protein-nucleic and interactions, and kits.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: June 6, 2006
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Tariq M. Rana, Natarajan Tamilarasu, Ikramul Huq
  • Site-specific protein modification
    Patent number: 7029846
    Abstract: Site-specific modified proteins and method for producing site-specific modified proteins using amino acid analogs are disclosed. Methods for labeling proteins at a desired site in the presence of nucleophilic side chains, including lysine and cysteine side chains, are also disclosed. Methods for labeling the site-specific modified proteins are also disclosed.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: April 18, 2006
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Tariq M. Rana, Natarajan Tamilarasu
  • Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
    Patent number: 6583309
    Abstract: The present invention relates to novel carbamates, ureas, and pharmaceutically acceptable salts thereof, compositions comprising the carbamate, urea, or a pharmaceutically acceptable salt thereof, and methods for treating or preventing cancer, inflammation, or a viral infection comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of the carbamate, urea, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: June 24, 2003
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Tariq M Rana, Seongwoo Hwang, Natarajan Tamilarasu
  • Site-specific protein modification
    Publication number: 20020106767
    Abstract: Site-specific modified proteins and method for producing site-specific modified proteins using amino acid analogs are disclosed. Methods for labeling proteins at a desired site in the presence of nucleophilic side chains, including lysine and cysteine side chains, are also disclosed. Methods for labeling the site-specific modified proteins are also disclosed.
    Type: Application
    Filed: October 4, 2001
    Publication date: August 8, 2002
    Applicant: University of Medicine and Dentistry of New Jersey
    Inventors: Tariq M. Rana, Natarajan Tamilarasu
  • Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
    Patent number: 6420591
    Abstract: The present invention relates to novel carbamates and pharmaceutically acceptable salts thereof; compositions comprising the carbamate or a pharmaceutically acceptable salt thereof; and methods for treating cancer, inflammation, or a viral infection comprising administering to a patient in need of such treatment a therapeutically effective amount of the carbamate or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 4, 2000
    Date of Patent: July 16, 2002
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Tariq M Rana, Seongwoo Hwang, Natarajan Tamilarasu